176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.34%
Revenue growth exceeding 1.5x Technology median of 3.77%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
10.62%
Gross profit growth exceeding 1.5x Technology median of 6.41%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
10.25%
EBIT growth 1.25-1.5x Technology median of 8.43%. Mohnish Pabrai would see if the advantage stems from superior cost management or product pricing.
10.25%
Operating income growth near Technology median of 10.21%. Charlie Munger might chalk it up to standard industry trends.
11.54%
Net income growth exceeding 1.5x Technology median of 6.26%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
13.33%
EPS growth exceeding 1.5x Technology median of 6.66%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
11.67%
Diluted EPS growth exceeding 1.5x Technology median of 7.33%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
-0.17%
Share reduction while Technology median is 0.13%. Seth Klarman would see a relative advantage if others are diluting.
-0.17%
Diluted share reduction while Technology median is 0.04%. Seth Klarman would see an advantage if others are still diluting.
151.45%
Dividend growth of 151.45% while Technology median is flat. Walter Schloss might appreciate at least a modest improvement.
-5.58%
Negative OCF growth while Technology median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-9.78%
Negative FCF growth while Technology median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
2374.66%
10Y revenue/share CAGR exceeding 1.5x Technology median of 41.54%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
1054.46%
5Y revenue/share growth exceeding 1.5x Technology median of 32.06%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
368.27%
3Y revenue/share growth exceeding 1.5x Technology median of 17.14%. Joel Greenblatt might see a short-term competitive advantage at play.
13570.50%
OCF/share CAGR exceeding 1.5x Technology median of 2.30% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
1434.13%
5Y OCF/share growth exceeding 1.5x Technology median of 17.74%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
447.93%
3Y OCF/share growth > 1.5x Technology median of 0.43%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
11683.51%
Net income/share CAGR exceeding 1.5x Technology median of 69.09% over a decade. Joel Greenblatt might see a standout compounder of earnings.
2880.39%
5Y net income/share CAGR > 1.5x Technology median of 57.95%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
609.21%
3Y net income/share CAGR > 1.5x Technology median of 26.96%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
1127.36%
Equity/share CAGR of 1127.36% while Technology median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
457.67%
5Y equity/share CAGR > 1.5x Technology median of 17.62%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
178.95%
3Y equity/share CAGR > 1.5x Technology median of 2.98%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
371.18%
Dividend/share CAGR of 371.18% while Technology is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
148.79%
5Y dividend/share CAGR of 148.79% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.
149.52%
3Y dividend/share CAGR of 149.52% while Technology is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
14.29%
Receivables growth far exceeding Technology median. Jim Chanos suspects potential red flags in revenue quality.
13.83%
Inventory growth of 13.83% while Technology median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
10.58%
Asset growth exceeding 1.5x Technology median of 0.00%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
18.55%
BV/share growth exceeding 1.5x Technology median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
-8.88%
Debt is shrinking while Technology median is rising. Seth Klarman might see an advantage if growth remains possible.
13.60%
R&D growth of 13.60% while Technology median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
8.37%
SG&A growth far above Technology median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.